Share On


"Implementing a Clinical Data Repository and Analytics Platform"

Implementing a Clinical Data Repository and Analytics Platform in 90 Days

Implementing a Clinical Data Repository and Analytics Platform in 90 Days

White Paper: eClinical Solutions, LLC

What is the need of having a Clinical Data Repository and Analytics solution?

Well, implementing a Clinical Data Repository (CDR) within a meaningful timeframe and a reasonable budget does not have to be a major IT initiative. With the right technology partner, a CDR can be implemented in 90 days. The capabilities are growing quickly and robust CDRs are available that allow companies to reap considerable value from clinical trial data.

This informative whitepaper talks about the desired functionality of the platform, and demonstrates the best practices for implementing a CDR while heeding to queries like:

  • How to maximize and utilize all clinical and operational data for real-time healthcare analytics?
  • What are the critical components in successfully implementing the CDR platform?
  • What are the technology benefits of implementing a next generation CDR?

Login With

Related White Papers

4 Pillars Pharma Distributors Can Stand On

By: Iptor Supply Chain Systems

To say competition in the pharmaceutical industry is fierce would be an understatement as the current trends in healthcare demands more from the supply chain partners. There is a pressing need for a more powerful, intuitive enterprise pharma solution. The pharma solutions are not only presented in response to current trends generally, but are also practical, affordable and available now. This whitepaper discusses the following four key pillars necessary to ensure competitive relevance in the pharmaceutical industry over the following five years: An intuitive enterprise solution for a pharma distribution center A reliable ordering process that hit pharma DCs every business day Specialized warehouse capabilities to rapidly respond to changing global pharmaceutical emergencies End-to-end track-and-trace technology along the supply chain

Preanalytical Considerations in the Design of Clinical Trials and Epidemiological Studies

By: Pacific Biomarkers

Preanalytical considerations in the design of clinical trials and epidemiologic studies are the cornerstones of the biochemical analyses. The main subject of clinical study design and epidemiology research is to monitor health, detect the harmful side effects and study the impact of therapeutic interventions. However, the largest contribution of errors in the clinical study design and epidemiology is associated with preanalytical phase. Do you think preanalytical variables are given sufficient consideration when designing clinical trials or epidemiologic studies? What strategies can be used to minimize preanalytical variables in clinical trials or epidemiologic studies? Is there a technology or a process to improve stability of sample analytes so that future investigations will not suffer from poor sample quality? What are the common challenges encountered during the preanalytical phase? This whitepaper discusses the factors to be considered during clinical trial designing and challenges faced during preanalytical phase such as: Availability of limited resources during the clinical designing. Technology and storage processes used to store the biomarker samples. Time elapsed between the sample collection and the stabilizing agents used to store the samples. Download this whitepaper with a brief insight into the issues of preanalytical variables and how they impact the clinical trial design and epidemiologic studies.

follow on linkedin follow on twitter follow on facebook 2024 All Rights Reserved | by: